Copyright
©The Author(s) 2016.
World J Cardiol. Nov 26, 2016; 8(11): 667-675
Published online Nov 26, 2016. doi: 10.4330/wjc.v8.i11.667
Published online Nov 26, 2016. doi: 10.4330/wjc.v8.i11.667
Table 1 Clinical characteristics of the study population
| Variable | Psoriasis (n = 40) | Controls (n = 12) | P value |
| Age, yr | 51 ± 12 | 49 ± 13 | 0.8 |
| Sex (male) (%) | 25 (63) | 7 (58) | 0.8 |
| PASI score | 11 ± 7 | - | - |
| Risk factors (%) | |||
| Hypertension | 14 (35) | 4 (33) | 0.9 |
| Hyperlipidemia | 14 (35) | 4 (33) | 0.9 |
| Current smoking | 19 (48) | 5 (42) | 0.8 |
| Medications (%) | |||
| Anti-hypertensives | 13 (33) | 4 (33) | 0.9 |
| Statins | 16 (40) | 5 (42) | 0.9 |
- Citation: Papadavid E, Diamanti K, Spathis A, Varoudi M, Andreadou I, Gravanis K, Theodoropoulos K, Karakitsos P, Lekakis J, Rigopoulos D, Ikonomidis I. Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk. World J Cardiol 2016; 8(11): 667-675
- URL: https://www.wjgnet.com/1949-8462/full/v8/i11/667.htm
- DOI: https://dx.doi.org/10.4330/wjc.v8.i11.667